Sustained activation of Erk1/2 MAPK and cell growth suppression by the insert-negative, but not the insert-positive isoform of the human calcitonin receptor

Journal of Endocrinology

Volumn 167, Issue 1, 2000, Pages 93-105

  Raggatt, L J ^a   Evdokiou, A ^a   Findlay, D M ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CALCITONIN RECEPTOR; CALCIUM; CYCLIC AMP; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P21;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FLUORESCENCE ACTIVATED CELL SORTER; GROWTH INHIBITION; HORMONE ACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033782646     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1670093     Document Type: Article

References (49)

1. Molecular cloning and functional expression of a third isoform of the human calcitonin receptor and partial characterisation of the calcitonin receptor gene
2. Alpha-adrenergic inhibition of proliferation in HepG2 cells stably transfected with the alpha 1B-adrenergic receptor through a p42 MAPkinase/p21 Cip1/WAF1-dependent pathway
3. A new action of parathyroid hormone. Receptor-mediated stimulation of extracellular acidification in human osteoblast-like SaOS-2 cells
4. Calcitonin alters behaviour of isolated osteoclasts
5. The calcitonin receptor stimulates Shc tyrosine phosphorylation and Erk1/2 activation. Involvement of Gi, protein kinase C, and calcium
6. Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: New approaches to therapy
7. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells
8. Calcitonin receptor-mediated growth suppression of HEK-293 cells is accompanied by induction of p21 WAF1/CIP1 and G2/M arrest
9. Properties of a calcitonin receptor and adenylate cyclase in BEN cells, a human cancer cell line
10. Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines
11. Calcitonin binding and degradation by two cultured human breast cancer cell lines (MCF7 and T47D)
12. Calcitonin: Regional distribution of the hormone and its binding sites in the human brain and pituitary
13. Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers
14. Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line
15. Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumour of bone. The first intracellular domain modulates ligand binding and signal transduction
16. 2+ indicators with greatly improved fluorescence properties
17. Cell growth control by G protein-coupled receptors: From signal transduction to signal integration
18. 2+ and collagenase production in bovine articular chondrocytes
19. Purification of calcitonin-like peptides from rat brain and pituitary
20. Isoforms of the rat calcitonin receptor: Consequences for ligand binding and signal transduction
21. The porcine calcitonin receptor promoter directs expression of a linked reporter gene in a tissue and developmental specific manner in transgenic mice
22. G-protein-coupled receptor heterodimerization modulates receptor function
23. Cloning and characterization of an abundant subtype of the human calcitonin receptor
24. Regulation of c-fos and c-jun expression by calcitonin in human breast cancer cells
25. Characteristics of selective activation of cyclic AMP-dependent protein kinase isoenzymes by calcitonin and prostaglandin E2 in human breast cancer cells
26. Transformation of mammalian cells by constitutively active MAP kinase kinase
27. Calcitonin
28. Calcitonin receptors of kidney and bone
29. Activation of the ERK/MAPK pathway by an isoform of rap1 GAP associated with Gα(i)
30. Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript
31. Phospholipase D- and protein kinase C isoenzyme-dependent signal transduction pathways activated by the calcitonin receptor
32. Calcitonin effects on growth and on selective activation of type II isoenzyme of cyclic adenosine 3':5'-monophosphate- dependent protein kinase in T 47D human breast cancer cells
33. Human placental calcitonin receptors
34. Inhibition of inositol phosphate second messenger formation by intracellular loop one of a human calcitonin receptor. Expression and mutational analysis of synthetic receptor genes
35. Cell cycle arrest mediated by the MEK/ mitogen-activated protein kinase pathway
36. Effects of the calciotrophic peptides calcitonin and parathyroid hormone on prostate cancer growth and chemotaxis
37. High-intensity Raf signal causes cell cycle arrest mediated by p21 Cip1
38. 2+ transients
39. Calcitonin is a physiological inhibitor of prolactin secretion in ovariectomized female rats
40. G(i)-mediated activation of mitogen-activated protein kinase (MAPK) pathway by receptor mimetic basic secretagogues of connective tissue-type mast cells: Bifurcation of arachidonic acid-induced release upstream of MAPK
41. Protein kinase C antagonizes pertussis-toxin-sensitive coupling of the calcitonin receptor to adenylyl cyclase
42. Hormone Receptors
43. A recombinant human calcitonin receptor functions as an extracellular calcium sensor
44. The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic
45. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor
46. Transfer of purified herpes vires thymidine kinase gene to cultured mouse cells
47. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21 Cip1
48. Cytoskeleton-dependent tyrosine phosphorylation of the p103 cas family member HEF1 downstream of the G-protein-coupled calcitonin receptor
49. Attenuation of calcitonin gene expression in pregnant rat uterus leads to a block in embryonic implantation